Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Research in Germany Web Portal Resource Report Resource Website |
Research in Germany Web Portal (RRID:SCR_007410) | data or information resource, portal, topical portal, training resource | The English web portal www.research-in-germany.de is an information platform and contact point for all looking to find out more about Germany''s research landscape and its latest research achievements. An interdisciplinary portal The portal not only informs researchers and scientists about what Germany has to offer them. It also covers the 17 future fields of the High-Tech Strategy and other fields of science and learning. In addition, it addresses a whole host of other players from politics and government, business and industry, or science and research, as well as our young researchers, of course. Editorial responsibility for the portal lies with the German Academic Exchange Service (DAAD), acting on behalf of the Federal Ministry of Education and Research (BMBF). The Research in Germany Land of Ideas Campaign The campaign to Promote Innovation and Research in Germany was launched in November 2006 to position German research in the international market. Since then, the campaign has been running worldwide under the brand Research in Germany Land of Ideas. Its declared goal is to highlight research in Germany and the advantages that it offers. This makes German research institutions more visible to our partners, customers and competitors. The campaign primarily aims to strengthen the networks that exist between German research institutions and our strategic partners worldwide. A further goal involves inspiring the world''s best minds in research and development to come to Germany to carry out their projects and then to make the most of the resulting opportunities that open up for both sides. Not to forget the goal of encouraging more international cooperation in science and research. job resource; funding resource; grants; training resource. | nif-0000-00494 | SCR_007410 | Research in Germany | 2026-09-19 12:51:29 | 0 | |||||||||||
|
University of South Alabama Department of Cell Biology and Neuroscience Resource Report Resource Website |
University of South Alabama Department of Cell Biology and Neuroscience (RRID:SCR_007531) | data or information resource, department portal, organization portal, portal | Offers graduate program and training. Areas include mechanisms of DNA repair, oligodendrocyte development and maturation, functional neuroanatomy, neurophysiology, cellular responses to oxidative stress, kinesin motor proteins and motility, regulation of nuclear transcription, and hormonal regulation of fertility. Program emphasizes understanding of biological principles at the cellular level and training in the anatomical disciplines to ensure success during career development. To achieve these objectives the department participates extensively in the Interdisciplinary Graduate Curriculum which teaches fundamental biological principles during the first year. After the first year, students select a mentor and begin to focus on a significant research topic. | nif-0000-02250 | http://southmed.usouthal.edu/com/scb/index2.html, http://www.usahealthsystem.com/cellbiology | SCR_007531 | 2026-09-19 12:51:31 | 0 | |||||||||||
|
Bernstein Network Computational Neuroscience Germany Resource Report Resource Website |
Bernstein Network Computational Neuroscience Germany (RRID:SCR_007413) | data or information resource, funding resource, job resource, organization portal, portal, training resource | The Bernstein Network for Computational Neuroscience, Germany, is a funding initiative of the German Federal Ministry of Education and Research that supports the development of this field in Germany. Understanding the brain is the prerequisite for creating new methods for prevention and treatment of diseases of the nervous system. It may also help developing new strategies for learning and teaching. It may even be used for the design of new, ''intelligent'' technical devices, such as neuroprostheses or more powerful computer systems. For investigating the brain, the interdisciplinary approach of computational neuroscience, in which experts in biology, physics, psychology, medicine, mathematics and engineering join forces, holds especially promising perspectives. By combining experiment, data analysis, theoretical modelling and computer simulations, computational neuroscience allows translating basic research to targeted applications. The Bernstein Network currently comprises more than 200 research groups at over 20 locations all over Germany. It entertains partnerships with more than 20 companies. Besides its research activities, the network offers attractive teaching and training options for young researchers. A large number of open positions are available, ranging from PhD students positions up to professorships. Keywords: grant, funding, resource, training, job, research, Network, Scientist, Teaching, biology, physics, psychology, medicine, mathematics, engineering, Computational, Neuroscience, Computational Neuroscience, Germany, | nif-0000-00497 | SCR_007413 | NNCN | 2026-09-19 12:51:29 | 0 | |||||||||||
|
UA Neuroscience GIDP Resource Report Resource Website |
UA Neuroscience GIDP (RRID:SCR_007494) | UA Neuroscience GIDP | data or information resource, department portal, organization portal, portal | The University of Arizona offers a Ph.D. through the Graduate Interdisciplinary Program in Neuroscience. The Program, administered by the Committee on Neuroscience, is designed to provide students with the knowledge and tools that they will need to embark on careers as educators and researchers in the field of neuroscience. Students participate in designing their own individually tailored programs that provide a thorough base of knowledge in the many facets of neuroscience as well as depth in chosen areas of specialization, and that enhance their abilities to think creatively and express themselves clearly. Because of the breadth of expertise represented by the faculty, students have access to educational and research training opportunities in areas ranging through molecular, cellular, systems, behavioral, cognitive, theoretical, and clinical neuroscience. The program currently enrolls 27 students. | has parent organization: University of Arizona; Arizona; USA | nif-0000-02132 | SCR_007494 | Program in Neuroscience, University of Arizona Graduate Interdisciplinary Program in Neuroscience | 2026-09-19 12:51:31 | 0 | |||||||||
|
University of California Santa Cruz, Department of Molecular, Cell and Developmental Biology Resource Report Resource Website |
University of California Santa Cruz, Department of Molecular, Cell and Developmental Biology (RRID:SCR_007497) | data or information resource, department portal, organization portal, portal | The Department of Molecular, Cell & Developmental Biology (MCD), with 20 faculty members, focuses on fundamental problems in the molecular, cell and developmental biology of animals and plants. The scope of research conducted in this group spans the broad range of modern biological research; from classical and molecular genetics to biochemistry and molecular biology. Research laboratories in the MCD Biology Department use both simple model organisms and vertebrate systems to study important biological processes, ranging from the mechanism of protein synthesis to the development and function of the nervous system. | nif-0000-02139 | http://www.mcd.ucsc.edu/ | SCR_007497 | UCSC | 2026-09-19 12:51:31 | 0 | ||||||||||
|
University of Rochester Department of Neuroscience Resource Report Resource Website |
University of Rochester Department of Neuroscience (RRID:SCR_007530) | data or information resource, department portal, organization portal, portal | Department that includes over 60 faculty members in ten different departments from both the School of Medicine and Dentistry and The College of Arts and Sciences. Several graduate and undergraduate degree programs exist on campus that are designed to meet the diverse needs and interests of students engaged in the study of the nervous system. The tight physical proximity of the medical and main campuses generates a highly collaborative and interactive Neuroscience community, and provides students with broad and flexible opportunities in their training. | has parent organization: University of Rochester; New York; USA | nif-0000-02248 | http://www.bcs.rochester.edu/neuroscience/ | SCR_007530 | 2026-09-19 12:51:31 | 0 | ||||||||||
|
Tufts University Department of Neuroscience Resource Report Resource Website 10+ mentions |
Tufts University Department of Neuroscience (RRID:SCR_007491) | data or information resource, department portal, organization portal, portal | The Graduate Program in Neuroscience at Tufts University School of Medicine is a member of the Sackler School Integrated Studies Program (ISP). The research programs of the 20 faculty members incorporate a broad range of approaches - from molecular to systems analysis - to understand the form and function of the nervous system, with a particular emphasis on the synapse. The graduate course of study, likewise, strongly emphasizes multidisciplinary training to prepare students for research careers in the complex field of neuroscience. Such training is additionally promoted through the technical expertise and research facilities offered by the Tufts Center for Neuroscience Research (CNR).It is based in newly renovated space in the Neuroscience Department, occupying three floors of the Tufts Medical School research complex in downtown Boston. | nif-0000-02118 | SCR_007491 | Tufts | 2026-09-19 12:51:30 | 27 | |||||||||||
|
Nclamp - data acquisition software for electrophysiology Resource Report Resource Website 1+ mentions |
Nclamp - data acquisition software for electrophysiology (RRID:SCR_003750) | data acquisition software, data processing software, software application, software resource | Data acquisition software that runs in conjunction with neuromatic. configured to work with Igor Pro on PC or Mac, instrutech or national instrument acquisition devices. Funded by The Medical Research Council (UK) Compatibility with WaveMetrics Igor Pro 5 and 6. Compatibility with Mac or PC. NIDAQ interfacing multifunction DAQ boards from National Instruments. Requires Igor NIDAQ Tools MX. ITC interfacing - data acquisition systems from InstruTech / Heka. Requires Igor ITC XOPs. Episodic acquisition (stim and sample). Continuous acquisition (currently for ITC users only). Online analysis, with ability to create your own analysis functions. Notes and Log Files which can be displayed within a table or notebook. Automatic saving of data and log folders to your hard drive. Flexible stimulus pulse generator with ability to use your own pulse waveforms. Instant accessibility to all of NeuroMatics and Igor Pros pre-existing data analysis functions. | nif-0000-00072 | SCR_003750 | Nclamp | 2026-09-19 12:50:24 | 5 | |||||||||||
|
Innovative Medicines Initiative Resource Report Resource Website 100+ mentions |
Innovative Medicines Initiative (RRID:SCR_003754) | IMI | organization | Initiative to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It does this by initiating and managing consortia composed of the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organizations, and medicines regulators. IMI is a public-private partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA), with a timeframe separated into two phases (2008-2013, 2014-2024) that are each defined by unique research agendas. The first phase (2008 2013) had four pillars that defined the focus of its research agenda: * Predicting safety: evaluating the safety of a compound during the pre-clinical phase of the development process and the later phases in clinical development. * Predicting efficacy: improving the ability to predict how a drug will interact in humans and how it may produce a change in function. * Knowledge management: utilization of information and data for predicting safety and efficacy. * Education and training: closing existing training gaps in the drug development process. Some of the consortia managed under IMI focused on specific health issues while others focused on broader challenges in drug development. Additionally, IMI launched a number of education and training projects during its first phases. The goal of the second phase (IMI2, 2014-2024) is to develop next generation vaccines and drugs. The focus is on delivering the right prevention and treatment for the right patient at the right time. There is a strong focus on the development of new medicines with an emphasis on tools and methods that accelerate patient access to new medicines. IMI2's agenda can be defined by four axes of research: * target validation and biomarker research (efficacy and safety) * adoption of innovative clinical trial paradigms * innovative medicines * patient-tailored adherence programs As part of its distinct goals, IMI2 aims to deliver: * 30% better success rate in clinical trials of priority medicines identified by the WHO; clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases in five years; * new and approved diagnostic markers for four of these diseases and at least two new medicines which could either be new antibiotics or new therapies for Alzheimer's disease. | drug development, drug, tool development, biomarker, data sharing, target validation, safety, efficacy, clinical trial, medicine, adherence program, vaccine, consortium, diagnostic marker, oncology, drug discovery |
is listed by: Consortia-pedia is related to: AddNeuroMed is related to: European Federation of Pharmaceutical Industries and Associations has parent organization: European Union has parent organization: European Federation of Pharmaceutical Industries and Associations is parent organization of: AddNeuroMed |
European Union FP7 ; Horizon 2020 ; EFPIA ; Other life science industries or organizations |
Wikidata: Q1664196, nlx_157984, grid.454814.8, ISNI: 0000 0004 0577 0821 | https://ror.org/019af4n30 | SCR_003754 | 2026-09-19 12:50:25 | 322 | |||||||
|
Global Health Innovative Technology Fund Resource Report Resource Website 10+ mentions |
Global Health Innovative Technology Fund (RRID:SCR_003753) | GHIT Fund, GHIT | institution | A consortium that focuses their efforts on discovering and developing new pharmaceutical drugs, vaccines (both preventive and therapeutic) and diagnostics against the infectious diseases that are prevalent in developing countries. The initial targets are those disorders designated by WHO as neglected tropical diseases prevalent in developing nations. The consortium aims to facilitate international partnerships that enable Japanese technology, innovations, and insights to play a more direct role in improving global health. Another goal of GHIT is to develop a new drug-discovery screening platform to assist the screening of compound libraries housed within Japanese companies and academic institutions. The vision is to have Japanese research organizations donate compounds, with the Fund reimbursing screening costs and leveraging screening programs of existing product-development partners. | global health, health, drug development, biomarker, consortium, drug, vaccine, diagnostics, healthcare, developing country, disease | is listed by: Consortia-pedia | Government of Japan ; Bill and Melinda Gates Foundation ; Pharmaceutical industry |
grid.475132.6, nlx_157983 | https://ror.org/02yfqyv95 | SCR_003753 | 2026-09-19 12:50:25 | 17 | |||||||
|
St. John's College of Pharmacy and Allied Health Professions Resource Report Resource Website |
St. John's College of Pharmacy and Allied Health Professions (RRID:SCR_003752) | St. Johns College of Pharmacy and Allied Health Professions | data or information resource, department portal, organization portal, portal | The College of Pharmacy and Allied Health Professions equips students with the education, training and support they need to meet the present and future demands professionals encounter as pharmacists, physician assistants, clinical laboratory scientists, toxicologists and radiologic technologists. The College is committed to helping students: * Focus on the responsibilities of public health and service * Appreciate the ever-changing character of the health professions * Enjoy a broad, general education * Pursue graduate study in specialized fields of interest Facilities Laboratory facilities in the College of Pharmacy and Allied Health Professions include state-of-the-art equipment used in pharmacology/toxicology, medicinal chemistry, industrial pharmacy and drug information. Our facilities include: GC-mass spectrophotometers; transmission and scanning electron microscopes; Mrs.; capillary GCs; preparative and analytical HPLCs; liquid scintillation and gamma counters; luminometers; dissolution apparatus; membrane potentiometers; atomic absorption spectrophotometers; polygraphs; high-speed and ultracentrifuges. In addition, we have sophisticated tissue-cultures laboratories, molecular pharmacology and molecular biology laboratories, as well as an AAALAC accredited animal facility. In addition to the main University computer, a fully equipped microcomputer laboratory is located adjacent to the main science complex. | pharmacy, undergraduate | has parent organization: St. Johns University; New York; USA | nif-0000-02067 | http://www.stjohns.edu/academics/undergraduate/pharmacy | SCR_003752 | St. John's University College of Pharmacy and Health Sciences | 2026-09-19 12:50:25 | 0 | |||||||
|
Medical Dictionary for Regulatory Activities Resource Report Resource Website 1+ mentions |
Medical Dictionary for Regulatory Activities (RRID:SCR_003751) | MEDDRA | controlled vocabulary, data or information resource, ontology | Ontology of Medical Dictionary for Regulatory Activities Terminology (MedDRA) | umls | is listed by: BioPortal | nlx_157471 | SCR_003751 | 2026-09-19 12:50:24 | 4 | |||||||||
|
Phenotree Resource Report Resource Website |
Phenotree (RRID:SCR_003591) | Phenotree | data or information resource, data set, service resource | Web server to search for genes involved in given phenotypic difference between mammalian species. The mouse-referenced multiple alignment data files used to perform the forward genomics screen is also available. The webserver implements one strategy of a Forward Genomics approach aiming at matching phenotype to genotype. Forward genomics matches a given pattern of phenotypic differences between species to genomic differences using a genome-wide screen. In the implementation, the divergence of the coding region of genes in mammals is measured. Given an ancestral phenotypic trait that is lost in independent mammalian lineages, it is shown that searching for genes that are more diverged in all trait-loss species can discover genes that are involved in the given phenotype. | gene, genotype, phenotype, alignment, trait, genome, alignment |
is related to: UCSC Genome Browser has parent organization: Stanford University; Stanford; California |
PMID:23022484 | Acknowledgement requested, Non-commercial, Free for personal use, Http://stanford.edu/site/terms.html | nlx_157736 | SCR_003591 | Forward Genomics - Phenotree server, Forward Genomics - Phenotree search | 2026-09-19 12:50:22 | 0 | ||||||
|
DTU Center for Biological Sequence Analysis Resource Report Resource Website 1000+ mentions |
DTU Center for Biological Sequence Analysis (RRID:SCR_003590) | CBS, DTU CBS | analysis service resource, data access protocol, production service resource, service resource, software resource, web service | Center for Biological Sequence Analysis of the Technical University of Denmark conducts basic research in the field of bioinformatics and systems biology and directs its research primarily towards topics related to the elucidation of the functional aspects of complex biological mechanisms. A large number of computational methods have been produced, which are offered to others via WWW servers. Several data sets are also available. The center also has experimental efforts in gene expression analysis using DNA chips and data generation in relation to the physical and structural properties of DNA. The on-line prediction services at CBS are available as interactive input forms. Most of the servers are also available as stand-alone software packages with the same functionality. In addition, for some servers, programmatic access is provided in the form of SOAP-based Web Services. The center also educates engineering students in biotechnology and systems biology and offers a wide range of courses in bioinformatics, systems biology, human health, microbiology and nutrigenomics. | nucleotide, sequence, amino acid, dna, microarray, molecule, immunology, protein function, protein structure, protein, post-translational, whole genome, sequence analysis |
has parent organization: Technical University of Denmark; Lyngby; Denmark is parent organization of: NESbase is parent organization of: O-GLYCBASE is parent organization of: OligoWiz is parent organization of: SignalP |
Danish National Research Foundation ; Danish Research Councils ; Danish Center for Scientific Computing ; Villum Kann Rasmussen Foundation ; Novo Nordisk Foundation ; European Union ; NIH |
nlx_12329 | http://www.cbs.dtu.dk/index.shtml | SCR_003590 | 2026-09-19 12:50:23 | 1475 | |||||||
|
California Integrated Data Exchange Resource Report Resource Website |
California Integrated Data Exchange (RRID:SCR_003747) | Cal INDEX | consortium, data or information resource, organization portal, portal | A three-year consortium that brings together insurers and health care providers to share information from approximately 9 million patients, with a goal that insights from the data will bring down healthcare costs and improve outcomes. It aims to be one of the largest health information exchanges in the country, with the goal of better connecting the vast, often disparate healthcare landscape across California. The database that will house patient data will be overseen by Orion Health, an independent eHealth software company. The information will only be used for clinical purposes. Academic research institutions can apply to use the Cal INDEX de-identified data for research to benefit the public good, such as population health initiatives. Cal INDEX has five main goals: * Improve the quality of care by providing clinicians with a unified statewide source of integrated patient information * Provide patients with a seamless transition between health plans or across various healthcare professionals and hospitals * Improve efficiency and reduce the cost of healthcare * Encourage healthcare technology innovation * Improve public health by providing de-identified data for medical research. Cal INDEX plans to launch at the end of 2014 with approximately 9 million health information records from combined members of Dignity Health and Blue Shield of California and Anthem Blue Cross. Cal INDEX is open to any health data contributor. Cal INDEX will establish a bi-directional data interface with providers to exchange data with EMRs and other hospital and office-based systems. | healthcare, data sharing, tool development, consortium, health information exchange, health information, health, california, clinical, electronic patient record, database, de-identified | is listed by: Consortia-pedia | Blue Shield of California ; Anthem Blue Cross |
nlx_157980 | SCR_003747 | 2026-09-19 12:50:24 | 0 | ||||||||
|
BioVacSafe Resource Report Resource Website 1+ mentions |
BioVacSafe (RRID:SCR_003745) | BioVacSafe | consortium, data or information resource, organization portal, portal | Project focused on developing cutting edge tools to speed up and improve the testing and monitoring of vaccine safety, both before and after release to the market. The three specific objectives of the project are: * the characterization of early inflammation induced by vaccines currently on the market and the identification and validation of biomarkers of early inflammation and allergic responses; * the identification and validation of early biomarkers of autoimmunity and their use to help identifying population at risk of developing autoimmunity; * the analysis of the incidence and epidemiology of autoimmune disease in the general population and the link to genetic background or previous events in the life of patients, including severe effects, such as anaphylactic shock. | safety, biomarker, consortium, clinical trial, inflammation, vaccine, infection, immunosafety, efficacy, autoimmunity, drug development, drug, test, monitor |
is listed by: Consortia-pedia has parent organization: University of Surrey; Surrey; United Kingdom |
Innovative Medicines Initiative 115308 | nlx_157978 | SCR_003745 | Biomarkers for Enhanced Vaccine Safety, Biovacsafe.eu, Biomarkers for enhanced vaccines immunosafety, Biomarkers for Enhanced Vaccine ImmunoSafety, BioVacSafe Project, BioVacSafe - Biomarkers for enhanced vaccines immunosafety | 2026-09-19 12:50:24 | 7 | |||||||
|
Coca-Cola Company Resource Report Resource Website 1+ mentions |
Coca-Cola Company (RRID:SCR_003749) | Coca-Cola, KO | commercial organization | An American multinational beverage corporation and manufacturer, retailer and marketer of nonalcoholic beverage concentrates and syrups, which is headquartered in Atlanta, Georgia. (Wikipedia) It is the world's largest beverage company, refreshing consumers with more than 500 sparkling and still brands. | beverage | Crossref funder ID: 100004367, ISNI: 0000 0004 0504 2170, grid.451378.c, Wikidata: Q3295867, nlx_158091 | https://ror.org/00yc8qw13 | SCR_003749 | KO, The Coca-Cola Company, Coca-Cola | 2026-09-19 12:50:24 | 2 | ||||||||
|
Seven Hills Bioreagents Resource Report Resource Website 1+ mentions |
Seven Hills Bioreagents (RRID:SCR_003748) | commercial organization | An Antibody supplier | nlx_152458 | SCR_003748 | 2026-09-19 12:50:24 | 3 | ||||||||||||
|
Advanced Immunization Technologies Resource Report Resource Website 1+ mentions |
Advanced Immunization Technologies (RRID:SCR_003741) | ADITEC | consortium, data or information resource, organization portal, portal | A consortium that aims to accelerate the development of immunization technologies for the next generation of human vaccines. The goals are to characterize the mode of action and conduct comparative effectiveness studies of: adjuvants, vectors, formulations, delivery devices, routes of immunization, homologous and heterologous primeboost schedules, on vaccine efficacy. As part of these clinical trials, the consortium will also investigate the impact of host factors such as age, gender, genetics and pathologies. The consortium hopes to use insights gained from their projects to advance the development of next-generation vaccines, using tools such as standardized animal models to select promising immunization technologies. The intended outcome of this partnership is to improve the vaccine development process by advancing: basic research, new technology development, and clinical trial methods. Scientific objectives: # Development of adjuvants, vectors, formulations, and delivery devices # Selection of candidates, routes of immunization, and prime-boost combinations in animal models # Assessment of the impact of host factors in response to vaccination # Development of concepts and tools from human immunization # Development of concepts and tools to address regulatory and ethical issues posed by novel immunization technologies # Creation of an internationally recognized training program for translational immunology and vaccinology. Data is shared across the research partners within and between the different workstreams. Additionally, the consortium has plans to create a clinical database that combines phenotypic and clinical information to study the immune response to influenza vaccination at a population level, in an effort to advance studies into the effects of genetic background, gender, and disease on vaccine response. | drug, consortium, drug development, biomarker, vaccine, immunization, vaccine technology, adjuvant, vector, route, device, prime-boost, host factor, system biology, technology, animal model, human immunology, immunology, phenotype, clinical, clinical trial, public health | is listed by: Consortia-pedia | European Union FP7 280873 | nlx_157968 | SCR_003741 | Advanced Immunization Technologies (ADITEC) | 2026-09-19 12:50:24 | 8 | |||||||
|
ABIRISK Resource Report Resource Website 10+ mentions |
ABIRISK (RRID:SCR_003740) | ABIRISK | consortium, data or information resource, organization portal, portal | A consortium that seeks to provide an integrated approach to anti-drug immunization by evaluating immunogenicity in hemophilia A, multiple sclerosis, and inflammatory diseases, and exploring new tools for protein drug immunogenicity. The data collected will be pooled in a single immunogenicity databank and will be standardized and used to develop models of anti-drug antibodies. By examining the correlation between patient and clinical factors and the incidence of immunogenicity, it hopes to reduce the regulatory and resource burdens of immunogenicity testing. The objectives of the consortium are: # Access to large cohorts of patients treated with marketed biopharmaceutical products # Complementary expertise for anti-drug antibodies (ADA) assays; standardization and characterization of ADA # Novel integrated approaches to characterize anti-drug lymphocyte responses # Development and validation of innovative prediction tools # Collection and integration of immunogenicity-related data and clinical relevance of ADA ABIRISK is grouped into five working projects, which communicate with one another and provide each other with results and data for analysis. The five working projects are: ADA assay development and validation and cohort management; cellular characterization and mechanisms of the AD immune response; evaluation and development of technologies for predicting immunogenicity; establishment of database, data analyses and integration; and project management and communication. | drug, consortium, drug development, biomarker, pharmacogenomics, biopharmaceutical product, immune response, immunogenicity, data sharing, immune system, biopharmaceutical, clinical |
uses: eTRIKS is listed by: Consortia-pedia |
Innovative Medicines Initiative 115303 | nlx_157967 | SCR_003740 | Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk, ABIRISK Project | 2026-09-19 12:50:24 | 17 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
